DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Conference Salt Lake City, UT – January 4, 2023 prn.to/3i9REIc

DiscGenics is proud to unveil two-year clinical results from their study of IDCT, a revolutionary allogeneic discogenic progenitor cell therapy for treating lumbar degenerative disc disease. The future of DDD treatment is looking brighter than ever! prnewswire.com/news-releases/…

Great news for those living with degenerative disc disease. DiscGenics' IDCT has been granted FDA RMAT Designation, bringing new hope for better treatment options. discgenics.com/news-posts/202…

All my experiences in the field of surgical devices have positioned me to have this opportunity as CEO of DiscGenics to potentially help millions of patients worldwide who are suffering daily from back pain. youtube.com/watch?v=pNR7Qs…

Join me at Caesars Palace Las Vegas from 3-3:25 PM PT as I present an update on DiscGenics' clinical study of our allogeneic disc progenitor cell therapy for lumbar disc degeneration. Exciting progress for #spinehealth! #IDCT investorsobserver.com/news/qm-pr/734…

IDCT, currently in development through DiscGenics , is set to become a game-changer for countless lives! Skeptical? Listen to Dr. Gornet's concise testimonial and learn about the amazing potential. #IDCT #DiscGenics

In this video from a discussion earlier this year, I delve into the transformative potential of DiscGenics to aid those battling disc degeneration. With the capability to touch the lives of nearly a quarter billion patients each year, at DiscGenics we're pioneering a shift in

Honored to represent DiscGenics at two significant events this October. I'll be sharing insights into our pioneering work in regenerative medicine at the East-West BioPharma Summit and the 2023 Cell & Gene Meeting on the Mesa. Looking forward to a month of learning and

Thrilled to share that DiscGenics has entered a pivotal collaboration with the U.S. Department of Veterans Affairs (VA). We're combining the potential of our proprietary Discogenic Cells with the VA's groundbreaking tissue-engineered endplate-modified disc-like angle ply